Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -26.76%18.68M | 25.86%19.24M | 57.90%60.18M | 132.22%589K | 84.92%18.81M | 59.12%25.5M | 11.22%15.29M | 177.12%38.12M | -122.14%-1.83M | 173.60%10.17M |
| Net income from continuing operations | 96.01%8.94M | 1,314.13%4.55M | 489.73%11.12M | 89.24%-747K | 2,180.49%7.68M | -15.41%4.56M | 59.72%-375K | 14.92%-2.85M | 30.63%-6.94M | -109.48%-369K |
| Operating gains losses | -22.81%1.16M | -1,706.77%-2.14M | 107.59%3.99M | 309.33%2.99M | -126.91%-632K | 182.27%1.51M | -95.31%133K | 837.16%1.92M | -3,652.63%-1.43M | 4,417.31%2.35M |
| Depreciation and amortization | -0.27%5.88M | 4.42%6.14M | 4.02%23.73M | 2.68%6.05M | 0.58%5.9M | 4.72%5.9M | 8.49%5.88M | 1.28%22.81M | 3.73%5.9M | 4.47%5.87M |
| Asset impairment expenditure | ---- | ---- | --750K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | -3.31%671K | 81.04%697K | 368.05%2.59M | 260.41%709K | 277.93%805K | 70.52%694K | 2.39%385K | -62.64%554K | -1,821.74%-442K | -64.38%213K |
| Deferred tax | 349.74%3.5M | -52.56%1.07M | 19,252.94%6.51M | 276.42%3.8M | -523.08%-330K | -63.49%778K | 2,643.82%2.26M | 96.17%-34K | 17.60%-2.15M | -91.73%78K |
| Other non cashItems | -288.03%-8.92M | 327.12%6M | -16.28%15.3M | -72.25%-11.1M | 46.82%24.29M | 22.13%4.75M | -161.62%-2.64M | -24.88%18.27M | -161.87%-6.45M | 213.79%16.55M |
| Change In working capital | 20.19%14.68M | -64.32%6.73M | 26.20%13.3M | -82.80%1.9M | -71.54%-19.68M | 179.76%12.22M | 186.58%18.85M | 172.72%10.54M | 34.02%11.06M | 57.07%-11.47M |
| -Change in receivables | 4.36%-14.95M | 114.50%186K | -41.69%-11.46M | -9.75%-10.88M | -27.84%16.33M | 7.57%-15.63M | 67.09%-1.28M | -488.89%-8.09M | -160.32%-9.91M | 263.60%22.63M |
| -Change in inventory | -15.87%15.45M | -6.16%17.92M | 16.29%20.98M | -5.34%10.43M | -16.43%-26.91M | 21.87%18.36M | 26.74%19.09M | 186.97%18.04M | 147.14%11.02M | -530.10%-23.11M |
| -Change in prepaid assets | 485.54%1.92M | -655.10%-816K | -293.48%-1.63M | 231.90%492K | -279.53%-1.77M | -85.82%-498K | -70.42%147K | -39.79%843K | -12.01%-373K | -31.41%987K |
| -Change in payables and accrued expense | 22.86%12.26M | -1,278.46%-10.56M | 2,154.75%5.4M | -82.02%1.86M | 38.83%-7.33M | 54.13%9.98M | 117.62%896K | -109.48%-263K | -33.52%10.33M | -12.37%-11.98M |
| Interest paid (cash flow from operating activities) | 20.03%-2.82M | 33.73%-3.44M | -1.47%-15.15M | -7.77%-3.47M | 44.39%-2.96M | -39.71%-3.53M | -34.48%-5.19M | 5.96%-14.93M | -28.51%-3.22M | -4.74%-5.33M |
| Tax refund paid | -221.31%-4.42M | 90.94%-364K | -206.21%-1.95M | -115.88%-293K | 63.41%3.73M | 3.91%-1.38M | -366.01%-4.02M | 526.96%1.84M | 302.97%1.85M | 41.31%2.29M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -26.76%18.68M | 25.86%19.24M | 57.90%60.18M | 132.22%589K | 84.92%18.81M | 59.12%25.5M | 11.22%15.29M | 177.12%38.12M | -122.14%-1.83M | 173.60%10.17M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 29.57%-4.04M | 68.10%-1.69M | -18.58%-17.59M | 25.84%-3.33M | -70.39%-3.22M | -0.47%-5.74M | -93.13%-5.31M | 27.04%-14.84M | 17.95%-4.49M | 62.72%-1.89M |
| Net PPE purchase and sale | 29.56%-3.7M | 74.18%-1.25M | -17.16%-15.8M | 28.43%-2.9M | -82.53%-2.79M | 3.58%-5.26M | -97.76%-4.85M | 22.07%-13.48M | 19.68%-4.05M | 62.99%-1.53M |
| Net intangibles purchas and sale | 29.71%-336K | 3.71%-441K | -32.77%-1.8M | 2.05%-431K | -18.89%-428K | -86.72%-478K | -54.73%-458K | 55.42%-1.35M | -2.33%-440K | 61.54%-360K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 29.57%-4.04M | 68.10%-1.69M | -18.58%-17.59M | 25.84%-3.33M | -70.39%-3.22M | -0.47%-5.74M | -93.13%-5.31M | 27.04%-14.84M | 17.95%-4.49M | 62.72%-1.89M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 52.02%-11.84M | -246.89%-17.55M | -82.96%-42.59M | -248.90%-5.13M | 13.38%-7.72M | -261.72%-24.68M | 54.00%-5.06M | -540.66%-23.28M | 223.76%3.45M | -147.17%-8.91M |
| Net issuance payments of debt | 57.71%-9.24M | -503.79%-14.83M | -168.77%-31.5M | -139.08%-2.37M | 23.54%-4.83M | -429.18%-21.86M | 66.49%-2.46M | -174.95%-11.72M | 3,203.08%6.05M | -129.40%-6.31M |
| Net common stock issuance | --0 | ---118K | ---681K | ---167K | ---288K | ---226K | --0 | --0 | --0 | --0 |
| Cash dividends paid | 0.12%-2.6M | 0.04%-2.6M | -0.25%-10.41M | 0.04%-2.6M | -0.23%-2.6M | -0.35%-2.6M | -0.46%-2.6M | -0.26%-10.38M | -0.46%-2.6M | -0.15%-2.59M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.18M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 52.02%-11.84M | -246.89%-17.55M | -82.96%-42.59M | -248.90%-5.13M | 13.38%-7.72M | -261.72%-24.68M | 54.00%-5.06M | -540.66%-23.28M | 223.76%3.45M | -147.17%-8.91M |
| Net cash flow | ||||||||||
| Beginning cash position | --0 | --0 | --0 | 174.45%7.87M | --0 | --4.92M | --0 | --0 | --2.87M | --3.49M |
| Current changes in cash | ---- | ---- | ---- | ---- | ---- | ---- | --4.92M | ---- | ---- | ---625K |
| End cash Position | --2.79M | --0 | --0 | --0 | 174.45%7.87M | --0 | --4.92M | --0 | --0 | --2.87M |
| Free cash from | -32.28%13.38M | 56.47%15.61M | 90.48%42.56M | 56.09%-2.77M | 112.27%15.59M | 91.56%19.77M | -9.27%9.98M | 439.54%22.34M | -326.74%-6.32M | 138.89%7.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.